Interleukin-6 in SARS-CoV2 risk stratification

F. Pereira da Silva (Guarda, Portugal), F. Luís (Guarda, Portugal), F. Jesus (Guarda, Portugal), É. Almeida (Guarda, Portugal), S. Braga (Guarda, Portugal), J. Ribeiro (Guarda, Portugal), R. Natal (Guarda, Portugal), J. Costa (Guarda, Portugal), M. Tavares (Guarda, Portugal), L. Ferreira (Guarda, Portugal)

Source: International Congress 2022 – COVID infections prognosis: risk factors and treatment

Session: COVID infections prognosis: risk factors and treatment
Session type: Thematic Poster
Number: 3380

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Pereira da Silva (Guarda, Portugal), F. Luís (Guarda, Portugal), F. Jesus (Guarda, Portugal), É. Almeida (Guarda, Portugal), S. Braga (Guarda, Portugal), J. Ribeiro (Guarda, Portugal), R. Natal (Guarda, Portugal), J. Costa (Guarda, Portugal), M. Tavares (Guarda, Portugal), L. Ferreira (Guarda, Portugal). Interleukin-6 in SARS-CoV2 risk stratification. 3380

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.